Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, PR China.
Department of Infectious Diseases, Hefei Second People's Hospital, Hefei 230001, Anhui Province, PR China.
Transl Res. 2024 Oct;272:140-150. doi: 10.1016/j.trsl.2024.03.002. Epub 2024 Mar 5.
Arginine methylation, a vital post-translational modification, plays a pivotal role in numerous cellular functions such as signal transduction, DNA damage response and repair, regulation of gene transcription, mRNA splicing, and protein interactions. Central to this modification is the role of protein arginine methyltransferases (PRMTs), which have been increasingly recognized for their involvement in the pathogenesis of various respiratory diseases. This review begins with an exploration of the biochemical underpinnings of arginine methylation, shedding light on the intricate molecular regulatory mechanisms governed by PRMTs. It then delves into the impact of arginine methylation and the dysregulation of arginine methyltransferases in diverse pulmonary disorders. Concluding with a focus on the therapeutic potential and recent advancements in PRMT inhibitors, this article aims to offer novel perspectives and therapeutic avenues for the management and treatment of respiratory diseases.
精氨酸甲基化是一种重要的翻译后修饰,在许多细胞功能中起着关键作用,如信号转导、DNA 损伤反应和修复、基因转录调控、mRNA 剪接和蛋白质相互作用。这种修饰的核心是蛋白质精氨酸甲基转移酶(PRMTs)的作用,它们越来越多地被认为参与了各种呼吸道疾病的发病机制。本综述首先探讨了精氨酸甲基化的生化基础,揭示了 PRMTs 调控的复杂分子调控机制。然后深入研究了精氨酸甲基化和精氨酸甲基转移酶在多种肺部疾病中的失调。最后,本文聚焦于 PRMT 抑制剂的治疗潜力和最新进展,旨在为呼吸道疾病的管理和治疗提供新的视角和治疗途径。